INTERNATIONAL CONGRESS OF
PharmacoGenetics
برنامه سخنرانی ها
Pharmacomicrobiomic Panel
2025/11/07
without time | Teaser of the international congress of pharmacogenetics
Congress teaser |
Speaker
Position of Speaker
Contact
Email: Congressteaser [at] icgcongress [dot] com
08:00-08:15 | Wellcome Message Of The Chairman Of The Pharmacomicrobiomic Panel
Dr. Farid Mohammadi |
Chairman
Position of Speaker
Contact
Email: FaridMohammadi [at] icgcongress [dot] com
08:15-08:45 | The Pharmacomicrobiome and Drug-Induced Skin Reactions
Dr. Farid Mohammadi |
Speaker
Position of Speaker
Contact
Email: FaridMohammadi [at] icgcongress [dot] com
08:45-09:15 | Pharmacobiomics , Applied & Clinical Implications
Dr. Forouhe Zahir-Jouzdani |
Speaker
Position of Speaker
* Associated professor, CRTSDL, Tehran University of Medical Sciences CEO, Arvan Pharmed Co
Contact
Email: ForouheZahir-Jouzdani [at] icgcongress [dot] com
09:15-09:45 | The Role Of Pharmacomicrobiomics In Personalized Medicine : The Emerging Contribution Of Artificial Intelligence
Dr. Mobin Hamidi Mondared |
Speaker
Position of Speaker
Skin and Leprosy Research Center, Tehran Universities of Medical Science, Tehran, Iran
Contact
Email: MobinHamidiMondared [at] icgcongress [dot] com
09:45-10:15 | Microbial Enzymes Of Pharmacological Importance
Dr. Nima Badri |
Speaker
Position of Speaker
Tehran university of medical sciences CEO of Mahta Arya Pharmed
Contact
Email: NimaBadri [at] icgcongress [dot] com
The Role of Nutrition in Pharmacogenetic Metabolism Panel
2025/11/08
08:00-08:15 | Wellcome Message Of The Chairman Of The Role Of Nutrition In Pharmacogenetic Metabolism Panel
Dr. Ghazale Eslamian |
Chairman
Position of Speaker
Assistant Professor Faculty of Nutrition and Food Technology Shahid Beheshti University of Medical Sciences Tehran, Iran
Contact
Email: GhazaleEslamian [at] icgcongress [dot] com
08:15-08:45 | Personalized Obesity Treatments Through Pharmacogenetic And Nutrigenetic
Dr. Ghazaleh Eslamian |
Speaker
Position of Speaker
Assistant Professor Faculty of Nutrition and Food Technology Shahid Beheshti University of Medical Sciences Tehran, Iran
Contact
Email: GhazalehEslamian [at] icgcongress [dot] com
08:45-09:15 | S-Adenosylmethionine (SAMe) : At The Crossroads Of Pharmacogenetics And Epigenetics-From Predicting Therapeutic Response To Dose Optimization
Dr. Azam Shakery |
Speaker
Position of Speaker
Shahid Beheshti University of Medical Sciences,Department of Cellular and Molecular Nutrition
Contact
Email: AzamShakery [at] icgcongress [dot] com
09:15-09:45 | Integration Of Pharmacogenomics And Nutrigenomics To Advance Personalized Health And Wellness
Dr. Ghazaleh Shimi |
Speaker
Position of Speaker
Department of Cellular and Molecular Nutrition, Faculty of Nutrition Science and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, 1981619573, Iran
Contact
Email: GhazalehShimi [at] icgcongress [dot] com
09:45-10:15 | Pharmacogenetics And Microbiome In Drug Metabolism
Dr. Emad Yuzbashian |
Speaker
Position of Speaker
Department of Biology, University of British Columbia, Kelowna, V1V 1V7, Canada.
Contact
Email: EmadYuzbashian [at] icgcongress [dot] com
Epigenetics and Cancer Signaling Panel
2025/11/09
08:00-08:15 | Wellcome Message Of The Chairman Of Epigenetics And Cancer Signaling Panel
Dr. Narjes Soleimanifar |
Chairman
Position of Speaker
Assistant Professor of Molecular Medicine; Molecular Immunology Research Center; Tehran University of Medical Sciences (TUMS).
Contact
Email: NarjesSoleimanifar [at] icgcongress [dot] com
08:15-08:45 | Epigenetics And Molecular Signaling Pathways In Breast Cancer : Biomarkers For Early Detection And Personalized Therapies
Dr. Yasamin Pahlavan |
Speaker
Position of Speaker
Biosensor Science and Technology Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
Contact
Email: YasaminPahlavan [at] icgcongress [dot] com
08:45-09:15 | Serum MicroRNA-9-5p Expression As A Biomarker For Breast Cancer : Evaluation And Target Gene Predictions
Dr. Mohammad Taghizadeh |
Speaker
Position of Speaker
Molecular Medicine Department, Faculty of advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Contact
Email: MohammadTaghizadeh [at] icgcongress [dot] com
09:15-09:45 | Regulation Of Cisplatin Resistance In Lung Cancer By Epigenetic Mechanisms
Dr. Mehrasa Asghari |
Speaker
Position of Speaker
Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Contact
Email: MehrasaAsghari [at] icgcongress [dot] com
09:45-10:15 | Methylation Signatures And Immunotherapy Synergy : Next-Generation Strategies For Gastric Cancer Management (2024-2025)
Dr. Mohadeseh Vishteh |
Speaker
Position of Speaker
Board member of the Iranian society of Molecular Medicine and Researcher in Department of Genetic, Baghiyatallah University of medical sciences, Tehran, Iran.
Contact
Email: MohadesehVishteh [at] icgcongress [dot] com
Oral presentations
A Bioinformatics Analysis of Common Genetic Variants in Nutrient-Related Genes Associated with Oral Cancer
Panel: The Role of Nutrition in Pharmacogenetic Metabolism
A Pan-Cancer Repurposing Framework for Saffron Bioactives Using Network-Centrality Filtering and cBioPortal Alteration Profiling
Panel: Epigenetics and Cancer Signaling
Berberine Targets Kinase-Dense Regulatory Hubs in Pancreatic Ductal Adenocarcinoma: Insights from Network Pharmacology
Panel: Artificial Intelligence and Genomics
Breast Cancer and Epigenetics, A Look at the Development and Progression
Panel: Epigenetics and Cancer Signaling
CVID vs SCID: How Flow Cytometry Reveals Critical T and B Cell Patterns
Panel: Pharmacomicrobiomic
Investigation of EZH2 Inhibitors and Epigenetic Alterations in the Development of Tamoxifen Resistance in Breast Cancer
Panel: Epigenetics and Cancer Signaling
MGMT Promoter Methylation as a Predictor of Temozolomide Response and Survival in Glioblastoma: A Systematic Review
Panel: Epigenetics and Cancer Signaling
MicroRNA Signaling in Cancer: Hidden Molecular Switches Controlling Tumor Growth
Panel: Pharmacomicrobiomic
Network-Pathway Integration Reveals Synergy Targets for Combination Therapy in Breast Cancer
Panel: Epigenetics and Cancer Signaling
New understanding of the reciprocal link between microRNA expression and epigenetic changes in human lung cancer
Panel: Epigenetics and Cancer Signaling
Pharmacogenetics of CYP450: A Pathway to Tailored Drug Therapy
Panel: Pharmaceutical Laws and Regulations
Pharmacogenetics of Opioid Analgesics: Toward Safer Pain Management
Panel: Pharmacomicrobiomic
PI3K/AKT/mTOR signaling pathway and the influence of miRNAs in cancer
Panel: Epigenetics and Cancer Signaling
Recent Progress in Glioblastoma Targeted Therapy via Smart Nanoparticle Delivery Systems
Panel: Epigenetics and Cancer Signaling
Utilizing Personalized Medicine to Diagnose and Treat Helicobacter pylori: Targeted Prevention and Treatment Strategies
Panel: Pharmacomicrobiomic
Poster presentations
A Network Pharmacology Analysis of Synergistic Anti-Cancer Effects of Combined AXL and PARP Inhibition
Panel: Pharmacomicrobiomic
A Pan-Cancer Repurposing Framework for Saffron Bioactives Using Network-Centrality Filtering and cBioPortal Alteration Profiling
Panel: Pharmacomicrobiomic
A Systematic Review of the Role of ABC Transporters in Breast Cancer Drug Resistance: Focus on ABCB1
Panel: Pharmacomicrobiomic
A Systems Pharmacology Approach to Food-Drug Interactions: Integrating Metabolism, Transport, and Genetics for Clinical Application
Panel: Pharmacomicrobiomic
AI-Assisted Ancestry-Specific Pharmacogenomics: Bridging the Representation Gap in Precision Medicine
Panel: Pharmacomicrobiomic
AI-driven Multi-Omics Integration for Personalized Cancer Risk Prediction and Prevention
Panel: Pharmacomicrobiomic
AI-Enhanced Pharmacogenomics: Toward Clinically Actionable and Personalized Drug Therapy
Panel: Pharmacomicrobiomic
Artificial Intelligence and Large Language Models (LLMs) in Genomic Medicine, Bioinformatics, and Digital Health: Real-Time Monitoring of Patient Drug Response Using Big Data and Personalized Treatment
Panel: Pharmacomicrobiomic
Artificial Intelligence Integration with CRISPR/Cas9: Toward Precision Genome Editing
Panel: Pharmacomicrobiomic
Artificial Intelligence Platform for Personalized Drug Therapy Based on Patient Genetic Profiles: Integrating Pharmacogenomics and Genomics for Optimizing Treatment Response and Prevention
Panel: Pharmacomicrobiomic
Berberine Targets Kinase-Dense Regulatory Hubs in Pancreatic Ductal Adenocarcinoma: Insights from Network Pharmacology
Panel: Pharmacomicrobiomic
Beyond Single-Gene Pharmacogenetics: AI-Driven Polygenic and Epigenetic Dose Prediction for Cancer Therapeutics
Panel: Pharmacomicrobiomic
Challenges in Nanomedicine and Personalized Medicine
Panel: Pharmacomicrobiomic
Computational Affinity Maturation of Ipilimumab: Site-directed Mutagenesis for Enhanced CTLA-4 Targeting
Panel: Pharmacomicrobiomic
Converging Genomics and Multi-Modal AI to Advance Precision Medicine
Panel: Pharmacomicrobiomic
CVID vs SCID: How Flow Cytometry Reveals Critical T and B Cell Patterns
Panel: Pharmacomicrobiomic
Deep Learning for Single-Cell Genomics: Trends, Challenges, and Opportunities
Panel: Pharmacomicrobiomic
Effect of personalized diet on CYP450 gene expression and Drug Response: a new approach in precision medicine
Panel: Pharmacomicrobiomic
Engineered Exosome-Based Cancer Vaccines: A Novel Strategy for Tumor Antigen Delivery and Immune Activation
Panel: Pharmacomicrobiomic
Epigenetic Modulation of Immune Checkpoints and Tumor Immune Signaling
Panel: Pharmacomicrobiomic
Epigenetic Modulation of Tumor Suppressor and Oncogene Networks
Panel: Pharmacomicrobiomic
Epigenetic Regulation of the PI3K/AKT/mTOR Pathway in Cancer: A Systematic Review of Mechanisms and Therapeutic Implications
Panel: Pharmacomicrobiomic
Ethical, Legal, and Regulatory Frameworks in Personalized Medicine and Pharmacogenetics
Panel: Pharmacomicrobiomic
Folate Intake Modulation of MTHFR C677T–Influenced Methotrexate Pharmacokinetics in Rheumatoid Arthritis: A Systematic Review
Panel: Pharmacomicrobiomic
From Sequencing to Survival: Current Evidence and Gaps in Implementing Large-Scale Genomic Profiling for Advanced Cancer
Panel: Pharmacomicrobiomic
Helicobacter pylori-induced inflammation's role in the development of an epigenetic field defect and its applicability as a measure of exposure and cancer risk.
Panel: Pharmacomicrobiomic
High Performance, Low Trust: Bridging the Gap Between Algorithmic Potential and Clinical Reality in AI-Driven Diagnostics
Panel: Pharmacomicrobiomic
Histone Deacetylase Inhibitor Sensitivity in EZH2-Mutant Diffuse Large B-Cell Lymphoma: A Systematic Review
Panel: Pharmacomicrobiomic
HLA-B*57:01 Screening to Prevent Abacavir Hypersensitivity and Its Effect on Virologic Suppression in HIV-1 Infection: A Systematic Review
Panel: Pharmacomicrobiomic
Impact of Nutritional Factors on Pharmacogenetic Profiles and Drug Response
Panel: Pharmacomicrobiomic
In Silico Investigation of Ellagic Acid as a Potential HDAC1 Inhibitor in Breast Cancer
Panel: Pharmacomicrobiomic
Integrating Pharmacogenomics with Patient Medication Experience: Ethical Considerations
Panel: Pharmacomicrobiomic
Lung Cancer Epigenetic Changes and Signalling Interactions: Mechanisms, Biomarkers, and Treatment Prospects
Panel: Pharmacomicrobiomic
Meta-Analysis of Gene Expression: Functional Food Potential of Iodine-Biofortified Lettuce in Caco-2 Cancer Cells
Panel: Pharmacomicrobiomic
MGMT Silencing and EGFR Amplification Synergy in Glioblastoma: Implications for Therapeutic Resistance
Panel: Pharmacomicrobiomic
Microbiome-Based Therapy in Personalized Medicine for Alzheimer’s Disease
Panel: Pharmacomicrobiomic
MicroRNA Signaling in Cancer: Hidden Molecular Switches Controlling Tumor Growth
Panel: Pharmacomicrobiomic
miR-21 Promoter Hypermethylation, PI3K/AKT Pathway Activation, and Prognosis in Hepatocellular Carcinoma: A Systematic Review
Panel: Pharmacomicrobiomic
mRNA-Based Cancer Vaccines: A Novel Approach to Target Tumor-Specific Antigens Through Immune Activation
Panel: Pharmacomicrobiomic
Nanotechnology-enabled pharmacogenomics: a revolution in cancer drug development
Panel: Pharmacomicrobiomic
Network-Pathway Integration Reveals Synergy Targets for Combination Therapy in Breast Cancer
Panel: Pharmacomicrobiomic
Nutrigenomics and Pharmacogenetics: The Interplay Between Diet and Drug Metabolism
Panel: Pharmacomicrobiomic
Omega-3 Fatty Acid Supplementation and CYP2C19 Genotype Effects on Clopidogrel Efficacy: A Systematic Review
Panel: Pharmacomicrobiomic
Optimization Strategies and Expanding Horizons of mRNA Vaccine Technology: Stability, Efficacy, and Beyond
Panel: Pharmacomicrobiomic
Pharmacogenetic Insights into EGFR, ALK, and BRAF Mutations and Their Role in Tyrosine Kinase Inhibitor Response
Panel: Pharmacomicrobiomic
Pharmacogenetics of CYP450: A Pathway to Tailored Drug Therapy
Panel: Pharmacomicrobiomic
Pharmacogenetics of Opioid Analgesics: Toward Safer Pain Management
Panel: Pharmacomicrobiomic
Pharmacogenomics-guided drug personalization in psychiatry: leveraging genetic biomarkers for treatment of depression and ADHD
Panel: Pharmacomicrobiomic
Pharmacogenomics-Guided Therapy Selection in Oncology: 2024–2025 Evidence and Implementation
Panel: Pharmacomicrobiomic
Pharmacological Targeting of the Cancer Epigenome: Recent Trends and Challenges
Panel: Pharmacomicrobiomic
Role of mitochondrial epigenetics in tumoral drug resistance
Panel: Pharmacomicrobiomic
Safety and Long Term Effectiveness of Psychotropic and Stimulant Medications in Children and Adolescents with ADHD: A Population Based Multi Provincial Cohort Study and Systematic Review
Panel: Pharmacomicrobiomic
Synergistic Effects of Engineered Green Environments and Advanced Gene Editing in Promoting Retinal Regeneration and Repair
Panel: Pharmacomicrobiomic
Synthetic Epigenetic Engineering of Extremophilic Bacteria: Prospects for Biotechnological and Space Applications
Panel: Pharmacomicrobiomic
Targeted Lipid-Based Nanoparticles for Non-Surgical Management of Advanced Lung and Pancreatic Cancers: A Smart Drug Delivery Approach
Panel: Pharmacomicrobiomic
The Role of Bioresonance in Modulating Epigenetics and Cancer Signaling: An Innovative Approach Based on Molecular Evidence and Resonance Technologies
Panel: Pharmacomicrobiomic
The Role of Epigenetics and Signaling Pathways in Liver Cancer: A Review of Mechanisms and Therapeutic Applications
Panel: Pharmacomicrobiomic
The Role of RASSF1A Gene Methylation in Lung Cancer and Prediction of Response to Targeted Therapies: A Systematic Review
Panel: Pharmacomicrobiomic
Trimethylbenzoyl Diphenylphosphine Oxide (TPO) in Gel Nail Polishes: A Comprehensive Review
Panel: Pharmacomicrobiomic
Utilizing Personalized Medicine to Diagnose and Treat Helicobacter pylori: Targeted Prevention and Treatment Strategies
Panel: Pharmacomicrobiomic
Vitamin D Pharmacogenomics in Cancer: Genetic and Metabolic Insights for Personalized Therapy
Panel: Pharmacomicrobiomic
Why Pharmacogenomics Predicts Drug Response with 90% More Accuracy: New Research Findings
Panel: Pharmacomicrobiomic
